A Study of Subcutaneously Administered Tocilizumab in Participants With Systemic Juvenile Idiopathic Arthritis
Clinical trial NCT01904292 · COMPLETED
Trial details
- NCT number
- NCT01904292
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2013-08-15
- Primary completion
- 2017-06-13
- Enrollment
- 52
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.